Cited by 44Hormonal and reproductive studiesSexual function and dysfunction studiesProstate Cancer Treatment and Research

Male sexual function can be maintained without aromatization: randomized placebo-controlled trial of dihydrotestosterone (DHT) in healthy, older men for 24 months

Sartorius, Gideon A., Ly, Lam P., Handelsman, David J.·2014·The Journal of Sexual Medicine

Abstract

INTRODUCTION: Male sexual function is highly androgen dependent but whether aromatization of testosterone (T) to estradiol is required remains contentious. AIM: This study aims to investigate the effects of selective estrogen deficiency induced by a nonaromatizable androgen, dihydrotestosterone (DHT), on sexual function of healthy middle-aged and older men. METHODS: Randomized clinical trial of daily transdermal DHT (70 mg) or placebo gel treatment in 114 healthy middle-aged and older (>50 years, mean 60.5 years) men without known prostate disease maintaining selective estrogen deficiency for 24 months. OUTCOME MEASURES AND ANALYSIS: The end points were responses to a psychosexual and mood questionnaire completed before, at 3 months, then at 6 monthly intervals during and 3 months after study. Data were analyzed by mixed model analysis of variance for repeated measures using age and body mass index (BMI) as covariates and including interactions of treatment with age and time-on-study. RESULTS: DHT treatment increased serum DHT with complete suppression of serum T, luteinizing hormone, follicle stimulating hormone, and estradiol throughout the 24-month study resulting in reduced spinal bone density. There were no spontaneous complaints, or discontinuations for, adverse effects on sexual function during the study. DHT administration had no effects on any of 33 measures of sexual function and mood, apart from a mild, but significant decrease in overall sexual desire, which was reversible after cessation of treatment. Increasing age and less often increasing BMI were associated with significant decreases in most aspects of sexual function. CONCLUSIONS: We conclude that aromatization plays only a minimal role in maintenance of sexual function in healthy eugonadal middle-aged or older men, but age and obesity are significantly associated with decreases in most aspects of self-reported sexual function and satisfaction. The dependence of male sexual function on aromatization may be conditional on age and obesity and can be overcome by a nonaromatizable androgen.

Integrity signals

Registry

Crossref · 10.1111/jsm.12550

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In healthy middle-aged men, male sexual function was fully maintained during 2 years of treatment with an exogenous androgen (DHT) despite sustained, complete suppression of endogenous testosterone.

    “Similar effects were also observed in healthy, middle-aged men in whom male sexual function was fully maintained (compared with placebo) during 2 years of treatment with an exogenous androgen (DHT) despite that treatment causing sustained, complete suppression of endogenous testosterone (68).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sartorius, G. A., Ly, L. P., & Handelsman, D. J.
Affiliations
The University of Sydney (AU)
Corresponding author
Handelsman, David J.
Venue
The Journal of Sexual Medicine
Published
2014-10-01
Volume
11
Issue
10
Pages
2562-2570
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W2123655543
Cited by
44
References
56
Citations by year
2026: 3 · 2025: 5 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 7 · 2016: 5 · 2015: 4 · 2014: 1
FWCI
4.56
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Sexual Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
Keywords
dihydrotestosterone, male sexual function, aromatization, older men, sexual desire, mood, age effects, obesity, bone mineral density, gonadotropin suppression
MeSH terms
Administration, Cutaneous, Aged, Androgens, Double-Blind Method, Estradiol, Humans, Luteinizing Hormone, Male, Middle Aged, Obesity, Dihydrotestosterone, Testosterone, Body Mass Index, Sexuality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review